From:  The association of brain-derived neurotrophic factor Val66Met polymorphism with stroke outcomes: a cross-sectional pilot study

 Depression and cognition of non-Met and Met carriers.

Outcomes Non-Met carriers (n = 77), mean (SD)Met carriers (n = 12), mean (SD)P values
Depression
CES-D16.9 (12.6)24.2 (14.8)0.08
Cognition
MoCA20.7 (5.2)19.8 (7.5)0.60
HVLT (verbal learning and memory)
Total recall19.9 (5.9)18.2 (5.5)0.38
Delayed6.5 (3.4)5.1 (3.5)0.22
Retention %75.2 (26.7)61.6 (32.9)0.15
WAIS-R digit (processing speed)35.7 (16.4)30.7 (21.3)0.39
D-KEFS (executive function)
    Color naming
    Time40.2 (17.2)52.1 (17.4)0.28
    Uncorrected0.7 (1.7)3.2 (6.4)0.23
    Self-corrected0.9 (1.2)1.6 (1.8)0.29
    Word reading
    Time34.6 (16.8)43.2 (20.5)0.12
    Uncorrected0.2 (0.9)0.9 (2.8)0.43
    Self-corrected0.3 (0.7)0.5 (1.0)0.40
    Inhibition
    Time90.4 (39.8)101.6 (45.9)0.41
    Uncorrected3.3 (6.0)4.5 (5.8)0.54
    Self-corrected2.3 (2.5)2.4 (3.7)0.90
    Inhibition switching
    Time104.1 (40.5)113.7 (55.3)0.52
    Uncorrected5.7 (6.6)5.0 (7.0)0.76
    Self-corrected1.6 (1.6)2.6 (3.5)0.46

CES-D: Center for Epidemiological Studies Depression; MoCA: Montreal Cognitive Assessment; HVLT: Hopkins Verbal Learning Test; WAIS-R: Wechsler Adult Intelligence Scale; D-KEFS: Delis-Kaplan Executive Function Test.